Cargando…
The Beta-adrenergic agonist, Ractopamine, increases skeletal muscle expression of Asparagine Synthetase as part of an integrated stress response gene program
Synthetic beta-adrenergic agonists (BA) have broad biomedical and agricultural application for increasing lean body mass, yet a poor understanding of the biology underpinning these agents is limiting further drug discovery potential. Growing female pigs (77 ± 7 kg) were administered the BA, Ractopam...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206132/ https://www.ncbi.nlm.nih.gov/pubmed/30374102 http://dx.doi.org/10.1038/s41598-018-34315-9 |
_version_ | 1783366307970809856 |
---|---|
author | Brown, David Ryan, Kevin Daniel, Zoe Mareko, Molebeledi Talbot, Richard Moreton, Joanna Giles, Tom C. B. Emes, Richard Hodgman, Charlie Parr, Tim Brameld, John M. |
author_facet | Brown, David Ryan, Kevin Daniel, Zoe Mareko, Molebeledi Talbot, Richard Moreton, Joanna Giles, Tom C. B. Emes, Richard Hodgman, Charlie Parr, Tim Brameld, John M. |
author_sort | Brown, David |
collection | PubMed |
description | Synthetic beta-adrenergic agonists (BA) have broad biomedical and agricultural application for increasing lean body mass, yet a poor understanding of the biology underpinning these agents is limiting further drug discovery potential. Growing female pigs (77 ± 7 kg) were administered the BA, Ractopamine (20 ppm in feed), or the recombinant growth hormone (GH), Reporcin (10 mg/48 hrs injected) for 1, 3, 7, 13 (n = 10 per treatment, per time point) or 27 days (n = 15 per treatment). Using RNA-sequencing and inferred pathway analysis, we examined temporal changes to the Longissimus Dorsi skeletal muscle transcriptome (n = 3 per treatment, per time point) relative to a feed-only control cohort. Gene expression changes were affirmed by quantitative-PCR on all samples (n = 164). RNA-sequencing analysis revealed that BA treatment had greater effects than GH, and that asparagine synthetase (Asns) was the 5(th) most significantly increased gene by BA at day 3. ASNS protein expression was dramatically increased by BA treatment at day 7 (p < 0.05). The most significantly increased gene at day 3 was activating transcription factor 5 (Atf5), a transcription factor known to regulate ASNS gene expression. Gene and protein expression of Atf4, another known regulator of Asns expression, was not changed by BA treatment. Expression of more than 20 known Atf4 target genes were increased by BA treatment, suggesting that BA treatment induces an integrated stress response (ISR) in skeletal muscle of pigs. In support of this, mRNA expression of sestrin-2 (Sesn2) and cyclin-dependant kinase 1 alpha (Cdkn1a), two key stress-responsive genes and negative regulators of cellular growth, were also strongly increased from day 3 of BA treatment. Finally, tRNA charging was the most significantly enriched pathway induced by BA treatment, suggesting alterations to the translational capacity/efficiency of the muscle. BA-mediated changes to the skeletal muscle transcriptome are highly indicative of an integrated stress response (ISR), particularly genes relating to amino acid biosynthesis and protein translational capacity. |
format | Online Article Text |
id | pubmed-6206132 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-62061322018-11-01 The Beta-adrenergic agonist, Ractopamine, increases skeletal muscle expression of Asparagine Synthetase as part of an integrated stress response gene program Brown, David Ryan, Kevin Daniel, Zoe Mareko, Molebeledi Talbot, Richard Moreton, Joanna Giles, Tom C. B. Emes, Richard Hodgman, Charlie Parr, Tim Brameld, John M. Sci Rep Article Synthetic beta-adrenergic agonists (BA) have broad biomedical and agricultural application for increasing lean body mass, yet a poor understanding of the biology underpinning these agents is limiting further drug discovery potential. Growing female pigs (77 ± 7 kg) were administered the BA, Ractopamine (20 ppm in feed), or the recombinant growth hormone (GH), Reporcin (10 mg/48 hrs injected) for 1, 3, 7, 13 (n = 10 per treatment, per time point) or 27 days (n = 15 per treatment). Using RNA-sequencing and inferred pathway analysis, we examined temporal changes to the Longissimus Dorsi skeletal muscle transcriptome (n = 3 per treatment, per time point) relative to a feed-only control cohort. Gene expression changes were affirmed by quantitative-PCR on all samples (n = 164). RNA-sequencing analysis revealed that BA treatment had greater effects than GH, and that asparagine synthetase (Asns) was the 5(th) most significantly increased gene by BA at day 3. ASNS protein expression was dramatically increased by BA treatment at day 7 (p < 0.05). The most significantly increased gene at day 3 was activating transcription factor 5 (Atf5), a transcription factor known to regulate ASNS gene expression. Gene and protein expression of Atf4, another known regulator of Asns expression, was not changed by BA treatment. Expression of more than 20 known Atf4 target genes were increased by BA treatment, suggesting that BA treatment induces an integrated stress response (ISR) in skeletal muscle of pigs. In support of this, mRNA expression of sestrin-2 (Sesn2) and cyclin-dependant kinase 1 alpha (Cdkn1a), two key stress-responsive genes and negative regulators of cellular growth, were also strongly increased from day 3 of BA treatment. Finally, tRNA charging was the most significantly enriched pathway induced by BA treatment, suggesting alterations to the translational capacity/efficiency of the muscle. BA-mediated changes to the skeletal muscle transcriptome are highly indicative of an integrated stress response (ISR), particularly genes relating to amino acid biosynthesis and protein translational capacity. Nature Publishing Group UK 2018-10-29 /pmc/articles/PMC6206132/ /pubmed/30374102 http://dx.doi.org/10.1038/s41598-018-34315-9 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Brown, David Ryan, Kevin Daniel, Zoe Mareko, Molebeledi Talbot, Richard Moreton, Joanna Giles, Tom C. B. Emes, Richard Hodgman, Charlie Parr, Tim Brameld, John M. The Beta-adrenergic agonist, Ractopamine, increases skeletal muscle expression of Asparagine Synthetase as part of an integrated stress response gene program |
title | The Beta-adrenergic agonist, Ractopamine, increases skeletal muscle expression of Asparagine Synthetase as part of an integrated stress response gene program |
title_full | The Beta-adrenergic agonist, Ractopamine, increases skeletal muscle expression of Asparagine Synthetase as part of an integrated stress response gene program |
title_fullStr | The Beta-adrenergic agonist, Ractopamine, increases skeletal muscle expression of Asparagine Synthetase as part of an integrated stress response gene program |
title_full_unstemmed | The Beta-adrenergic agonist, Ractopamine, increases skeletal muscle expression of Asparagine Synthetase as part of an integrated stress response gene program |
title_short | The Beta-adrenergic agonist, Ractopamine, increases skeletal muscle expression of Asparagine Synthetase as part of an integrated stress response gene program |
title_sort | beta-adrenergic agonist, ractopamine, increases skeletal muscle expression of asparagine synthetase as part of an integrated stress response gene program |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206132/ https://www.ncbi.nlm.nih.gov/pubmed/30374102 http://dx.doi.org/10.1038/s41598-018-34315-9 |
work_keys_str_mv | AT browndavid thebetaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram AT ryankevin thebetaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram AT danielzoe thebetaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram AT marekomolebeledi thebetaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram AT talbotrichard thebetaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram AT moretonjoanna thebetaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram AT gilestomcb thebetaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram AT emesrichard thebetaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram AT hodgmancharlie thebetaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram AT parrtim thebetaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram AT brameldjohnm thebetaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram AT browndavid betaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram AT ryankevin betaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram AT danielzoe betaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram AT marekomolebeledi betaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram AT talbotrichard betaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram AT moretonjoanna betaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram AT gilestomcb betaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram AT emesrichard betaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram AT hodgmancharlie betaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram AT parrtim betaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram AT brameldjohnm betaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram |